Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
暂无分享,去创建一个
D. Panebianco | M. Yablonski | M. Cyrlin | M. B. Shields | E. Lippa | M. Wilkerson | D. Esposito | R. Fazio | M. Yablonski | D. Deasy | M. Shields | Denise Deasy | Mark Wilkerson | Donna Esposito | Deborrah Panebianco | Roselyn Fazio